Breast cancer surgeon Monica Morrow spoke about preventive treatment options for women with a BRCA gene mutation, which increases the risk for breast and ovarian cancer.
Reconstructive surgeon Colleen McCarthy spoke about improvements in breast reconstruction following Angelina Jolie’s announcement that she underwent a prophylactic mastectomy after learning she carries the BRCA gene mutation, which increases the risk for breast and ovarian cancer.
Clinical Genetics Service Chief Kenneth Offit spoke about genetic testing and the increased risk of breast and ovarian cancer for women with BRCA gene mutations.
Breast cancer surgeon Deborah Capko explained the kind of prophylactic breast surgery Angelina Jolie received after learning she carries the BRCA gene mutation, which increases the risk for breast and ovarian cancer.
Breast cancer surgeon Alexandra Heerdt commended Angelina Jolie for sparking a conversation about hereditary breast cancer after learning she carries the BRCA gene mutation, which increases the risk for breast and ovarian cancer.
Immigrant Health and Cancer Disparities Service Chief Francesca Gany commented on a policy statement from the American Academy of Pediatrics that stated that its members should pay special attention to the healthcare needs of immigrant children.
Clinical psychologist Allison Applebaum commented on a study that found that spiritual patients who reported high levels of support from their religious communities were more likely to receive aggressive end-of-life treatment.
Physician-scientist Charles Sawyers commented on the FDA’s new breakthrough designation, designed to accelerate the review process for drugs that treat life-threatening conditions.
A group of doctors inspired by Memorial Sloan-Kettering’s decision not to carry a new colorectal cancer drug (Zaltrap®) due to its cost banded together in hopes of persuading some leading pharmaceutical companies to bring prices down.
A group of more than 100 influential cancer specialists, inspired by Memorial Sloan-Kettering’s decision not to carry a new colorectal cancer drug due to its cost, have banded together in hopes of persuading some leading pharmaceutical companies to bring prices down.
Epidemiologist Helena Furberg commented on a study that found that men who are overweight are more likely to have precancerous lesions detected in a benign prostate biopsy and are at a greater risk for subsequently developing prostate cancer.
Interventional radiologist Constantinos Sofocleous discussed a study he led that found that irreversible electroporation, a technique that sends electrical pulses via tiny needles directly to tumors, successfully destroys cancer cells without harming nearby healthy cells.
